OXB
在场
高管
查看带有其 23 名主要高管的组织结构图
OXB 搜索最多的简介
- Frank Mathias, Chief Executive Officer and Director
- Robert Ghenchev, Non-Executive Director
- Heather Preston, Non-Executive Director
高管在OXB变化
- Colin Bond已作为Non-Executive Director加入公司 (新闻发布的2024十一月19号).
- Laurence Espinasse已作为Non-Executive Director加入公司 (新闻发布的2024七月26号).
- Stuart Paynter, Chief Financial Officer and Director, 将于 20249月2 退休 (新闻发布的2024七月18号).
创建提醒
跟踪 OXB 的高管变动
药店
OXB 拥有 1,834 家竞争者，其中包括 Pfizer (美国(美洲))、Eli Lilly (美国(美洲)) 和 Roche (瑞士)。
Popular M&A news in 药店
- Clario 已收购 NRx Pharmaceuticals (公布2025三月18号).
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
药店 行业的其他推荐联系人
消息
OXB 的最新新闻稿
- Press Releases - OXB - Page 23
- Acquisition of OXB France - Oxford Biomedica
- Oxford Biomedica to host webinar showcasing the TetraVecta™ system | OxfordBiomedica
- Oxford Biomedica expands agreement with Cabaletta Bio; adding new viral vector programme for CD19-CAR T therapies | OxfordBiomedica
- Oxford Biomedica launches the TetraVecta™ System | OxfordBiomedica
- Oxford Biomedica to Present at 41st Annual J.P Morgan Healthcare Conference | OxfordBiomedica
- Oxford Biomedica Solutions forms new partnerships with three biotechnology companies | OxfordBiomedica
- Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer | OxfordBiomedica
- Oxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 million | OxfordBiomedica
- Amendment of Short-Term Loan Facility into new Term Loan Facility With Oaktree | OxfordBiomedica
- View more press releases Close
